Multiple sclerosis (MS) is a disease of relatively low incidence in the United Kingdom. Because of its long clinical course, however, its prevalence is moderately high and it makes a considerable impact on individuals, families, and on the health and social services. The inclusion in this review of the epidemiology, genetics, and health care of MS is intended to stress the inter-relationship between these three aspects of the disorder.
MS is a demyelinating disease of the central nervous system. As a chronic disease, it offers a number of challenges to the epidemiologist. Firstly The British Society of Rehabilitation Medicine,99 while emphasising that "a search for the cause and pathogenesis of MS is a first priority in research", recognises the need for "longitudinal surveys in which quantitative medical, functional and social information are collected" in order "to understand the processes by which impairment leads to disability and handicap" and to "identify ways in which the quality of life of those who have it can be protected".
The Nuffield Institute for Health, in collaboration with the Department of Neurology, St James' University Hospital, Leeds, is currently conducting a population based study of MS in West Yorkshire which will address some of these issues.
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